Compare TWI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWI | LXRX |
|---|---|---|
| Founded | 1890 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 518.0M | 447.0M |
| IPO Year | 1993 | 2000 |
| Metric | TWI | LXRX |
|---|---|---|
| Price | $7.99 | $1.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $11.50 | $3.23 |
| AVG Volume (30 Days) | 765.5K | ★ 1.7M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,801,577,000.00 | $70,864,000.00 |
| Revenue This Year | N/A | $56.61 |
| Revenue Next Year | $4.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1255.21 |
| 52 Week Low | $5.93 | $0.28 |
| 52 Week High | $10.94 | $1.66 |
| Indicator | TWI | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 34.92 |
| Support Level | $7.69 | $1.12 |
| Resistance Level | $8.24 | $1.24 |
| Average True Range (ATR) | 0.29 | 0.07 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 39.45 | 6.25 |
Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.